Probuphine

FDA rejects Titan drug for opioid dependence

FDA rejects Titan drug for opioid dependence

Reuters

Questions That Must Be Answered For The Success Of Probuphine

Questions That Must Be Answered For The Success Of Probuphine

Seeking Alpha

Titan Shares Rise After FDA Panel Backs Opioid Implant

Titan Shares Rise After FDA Panel Backs Opioid Implant

Bloomberg

Titan Pharma: FDA Panel Live Blog

Titan Pharma: FDA Panel Live Blog

TheStreet.com

Titan’s Probuphine Dosing May Need Review, FDA Staff Says

Titan’s Probuphine Dosing May Need Review, FDA Staff Says

Bloomberg

Titan Presents Compelling Opportunity Ahead Of PDAC Vote

Titan Presents Compelling Opportunity Ahead Of PDAC Vote

Seeking Alpha

Titan Pharma: Run-Up Trade Into March FDA Panel

Titan Pharma: Run-Up Trade Into March FDA Panel

TheStreet.com

Titan Files NDA on Probuphine; Partner Waits

Titan Files NDA on Probuphine; Partner Waits

Yahoo/Reuters

Titan Enters Exclusive Talks To Partner Probuphine

Titan Enters Exclusive Talks To Partner Probuphine

Seeking Alpha

Titan Pharma aims to carry Ph3 success to FDA meeting

Titan Pharma aims to carry Ph3 success to FDA meeting

Fierce Biotech